Latest Articles

Publication Date
Research sheds light on key drivers of endometrial cancer - The National Tribune

Research sheds light on key drivers of endometrial cancer The National Tribune

Published: Feb. 11, 2026, 2:10 p.m.
Endometrial Cancer Treatment Market Is Going to Boom |• Merck & Co. • Bristol-Myers Squibb - openPR.com

Endometrial Cancer Treatment Market Is Going to Boom |• Merck & Co. • Bristol-Myers Squibb openPR.com

Published: Feb. 11, 2026, 12:24 p.m.
Dual role of the endometrial microbiome-immune axis: From endometrial | IJWH - Dove Medical Press

Dual role of the endometrial microbiome-immune axis: From endometrial | IJWH Dove Medical Press

Published: Feb. 11, 2026, 9:02 a.m.
GLP-1s Plus Progestins Tied to Lower Endometrial Cancer Risk - Medscape

GLP-1s Plus Progestins Tied to Lower Endometrial Cancer Risk Medscape

Published: Feb. 11, 2026, 8:49 a.m.
Dietary Caloric Restriction Suppresses Endometriosis by Inhibiting STAT3/ERK Pathways.

Endometriosis is a chronic, estrogen-dependent inflammatory condition that affects approximately 10% of reproductive-age women and is frequently associated with infertility and pelvic pain. Unlike many estrogen-dependent disorders, epidemiologic studies have …

Published: Feb. 11, 2026, midnight
Amygdalin inhibits 17β-estradiol-induced mesenchymal transition through TGF- β/Smad signaling in normal and endometriotic endometrial epithelial cells.

Endometriosis is a common gynecological disorder characterized by chronic pelvic pain, infertility, and systemic symptoms, with currently limited treatment options. Amygdalin, a cyanogenic glycoside derived from bitter apricot kernels, has …

Published: Feb. 11, 2026, midnight
MSK Endometrial Cancer e-Tumor Board - Medscape

MSK Endometrial Cancer e-Tumor Board Medscape

Published: Feb. 10, 2026, 11:06 p.m.
Why is Inoperable Endometrial Cancer Relevant at the 2026 ACRO Summit? - CancerNetwork

Why is Inoperable Endometrial Cancer Relevant at the 2026 ACRO Summit? CancerNetwork

Published: Feb. 10, 2026, 8:43 p.m.
AstraZeneca Imfinzi Approved in India for Endometrial Cancer - Rediff MoneyWiz

AstraZeneca Imfinzi Approved in India for Endometrial Cancer Rediff MoneyWiz

Published: Feb. 10, 2026, 8:42 a.m.
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in endometrial cancer - Express Pharma

AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in endometrial cancer Express Pharma

Published: Feb. 10, 2026, 6:40 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!